ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,117.52
-0.43%
US Tech 100
21,495.60
-0.39%
다우존스 지수
44,176.65
-1.01%
Bitcoin
98,350.00
0.03%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Recursion Pharmaceuticals Inc (RXRX) 시세

Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

NASDAQ
10.35
-0.52
(-4.78%)
마감 21 2월 6:00AM
15분 지연
10.37
0.02
(0.19%)
시간외 거래: 9:59AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
10.37
매수가
10.31
매도가
10.36
거래량
38,573,159
9.52 일간 변동폭 10.87
5.60 52주 범위 15.74
market_cap
2.972B
전일 종가
10.87
개장가
10.86
최근 거래 시간
30
@
10.3694
마지막 거래 시간
재정 규모
US$ 391,277,832
VWAP
10.1438
평균 볼륨(3m)
21,551,944
발행 주식
286,640,833
배당수익률
-
주가수익률
-9.03
주당순이익(EPS)
-1.14
매출
44.58M
순이익
-328.07M

Recursion Pharmaceuticals Inc 정보

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery... Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.recursion.com
본부
Wilmington, Delaware, USA
설립됨
-
Recursion Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker RXRX. The last closing price for Recursion Pharmaceuticals was US$10.87. Over the last year, Recursion Pharmaceuticals shares have traded in a share price range of US$ 5.60 to US$ 15.74.

Recursion Pharmaceuticals currently has 286,640,833 shares in issue. The market capitalisation of Recursion Pharmaceuticals is US$3.12 billion. Recursion Pharmaceuticals has a price to earnings ratio (PE ratio) of -9.03.

Recursion Pharmaceuticals (RXRX) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

강세

순 프리미엄

6M

Calls / Puts

1,180.00%

매수 / 매도

93.33%

OTM / ITM

88.24%

Sweeps 비율

0.78%

RXRX 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
8 시간 전
RXRX (-4.78%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
8 시간 전
RXRX (-4.78%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 2월 2025
RXRX (-4.78%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
07 2월 2025
RXRX (-4.78%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 2월 2025
RXRX (-4.78%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
12.1125.54479418898.2612.367.945801101210.39173734CS
42.7335.73298429327.6412.366.72314340198.70380662CS
123.8759.53846153856.512.365.93215519447.93233924CS
263.244.6304044637.1712.365.6125970347.55473742CS
52-2.68-20.536398467413.0515.745.691717508.14912969CS
1560.313.0815109343910.0616.7454.5448389318.67922868CS
260-19.63-65.43333333333042.814.5439626719.29325973CS

RXRX - Frequently Asked Questions (FAQ)

What is the current Recursion Pharmaceuticals share price?
The current share price of Recursion Pharmaceuticals is US$ 10.37
How many Recursion Pharmaceuticals shares are in issue?
Recursion Pharmaceuticals has 286,640,833 shares in issue
What is the market cap of Recursion Pharmaceuticals?
The market capitalisation of Recursion Pharmaceuticals is USD 3.12B
What is the 1 year trading range for Recursion Pharmaceuticals share price?
Recursion Pharmaceuticals has traded in the range of US$ 5.60 to US$ 15.74 during the past year
What is the PE ratio of Recursion Pharmaceuticals?
The price to earnings ratio of Recursion Pharmaceuticals is -9.03
What is the cash to sales ratio of Recursion Pharmaceuticals?
The cash to sales ratio of Recursion Pharmaceuticals is 66.5
What is the reporting currency for Recursion Pharmaceuticals?
Recursion Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Recursion Pharmaceuticals?
The latest annual turnover of Recursion Pharmaceuticals is USD 44.58M
What is the latest annual profit for Recursion Pharmaceuticals?
The latest annual profit of Recursion Pharmaceuticals is USD -328.07M
What is the registered address of Recursion Pharmaceuticals?
The registered address for Recursion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Recursion Pharmaceuticals website address?
The website address for Recursion Pharmaceuticals is www.recursion.com
Which industry sector does Recursion Pharmaceuticals operate in?
Recursion Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MNDRMobile health Network Solutions
US$ 0.934099
(183.66%)
452.2M
XOSXos Inc
US$ 6.245
(99.52%)
96.59M
BPTHBio Path Holdings Inc
US$ 0.20
(51.29%)
1.69M
STSSSharps Technology Inc
US$ 0.5185
(44.55%)
76.27M
YSXTYSX Tech Company Ltd
US$ 3.4999
(42.85%)
461.74k
WOKWORK Medical Technology Group Ltd
US$ 1.30
(-47.79%)
116.01M
EDITEditas Medicine Inc
US$ 2.0556
(-35.76%)
16.54M
MTLSMaterialise NV
US$ 5.98
(-35.14%)
2.8M
MULNMullen Automotive Inc
US$ 5.125
(-28.32%)
1.35M
JTAIJet AI Inc
US$ 7.32
(-27.88%)
8M
MNDRMobile health Network Solutions
US$ 0.934099
(183.66%)
451.07M
PLTRPalantir Technologies Inc
US$ 106.27
(-5.17%)
228.01M
ADTXAditxt Inc
US$ 0.1156
(-10.11%)
202.11M
SMCISuper Micro Computer Inc
US$ 59.27
(-1.63%)
174.43M
APTOAptose Biosciences Inc
US$ 0.188
(25.42%)
164.63M

RXRX Discussion

게시물 보기
bwrbad bwrbad 13 시간 전
Big volume -- could be green EOD
👍️0
bwrbad bwrbad 3 일 전
once cross 36 - it is open sky.
everyday dips are the advantage point
buying the $200 -$300 /sh stock of 2025 at $11 -$36
👍️0
bwrbad bwrbad 3 일 전
could move $3 -$5 today
👍️0
bwrbad bwrbad 5 일 전
https://x.com/RecursionChris/status/1747265218437349847
👍️0
TucsonPhil TucsonPhil 6 일 전
I'd wager that undisclosed information is at play, but that wouldn't be legal, so couldn't possibly be the case.
👍️0
3antar 3antar 6 일 전
So why do you think it keeps going higher! 
👍️0
bwrbad bwrbad 6 일 전
blindfold buy at 20 - 30 then the jump 100 - 200
👍️0
bwrbad bwrbad 7 일 전
RXRX
👍️0
TucsonPhil TucsonPhil 7 일 전
They announce a mixed shelf (dilution), and the price spikes?
👍️0
bwrbad bwrbad 1 주 전
RXRX just started little little sprinting step before planting the pole and jump over that record high pole vault bar
👍 1
bwrbad bwrbad 1 주 전
invest - - soon --- before out of reach.
👍️0
bwrbad bwrbad 1 주 전
this is a stock will gain 200-300% in a single day-- but today - no - it will go back to +3c or -3c in 1h
👍️0
TucsonPhil TucsonPhil 2 주 전
This level of result, will make this company fly:

https://www.globenewswire.com/news-release/2025/02/05/3021646/0/en/Recursion-Presents-Phase-2-Data-for-REC-994-in-CCM-in-Late-Breaking-Oral-Presentation-at-the-International-Stroke-Conference.html
👍️ 1
bwrbad bwrbad 2 주 전
generative AI in making medical miracle
👍️0
bwrbad bwrbad 2 주 전
REC-994 MRI-based brainstem lesion volume reduction : place a $M maker brick now
👍️0
bwrbad bwrbad 2 주 전
70 institution 30 public--that's how RXRX drug working now
👍️0
bwrbad bwrbad 3 주 전
YouTube influencer position - write or call cGibson@recursion.com
👍️0
TucsonPhil TucsonPhil 3 주 전
Exactly, when we see the lending fees start to rise, then I will buy more. Brokers always make money, even when investors lose.
👍️0
bwrbad bwrbad 3 주 전
they all do etard fidal TDA, but that gives the opportunity to buy low. This RxRx defines the future of MED world in AI stage- just buying little little within affordability. definitively it will grow like MSTF GOOG AAPL NVDA AMZN.., All drug lords pfizer, j&j eli, merck roche AZ BMS are lining up behind, just give few months to a year for first $100
👍️0
TucsonPhil TucsonPhil 3 주 전
Fidelity is loaning shares to shorts.
👍️0
bwrbad bwrbad 3 주 전
next piece of clinical update will take it above 20 and after that it is in different league.
👍️0
bwrbad bwrbad 4 주 전
Sure looks like early days of ISRG ILMN,
👍️0
TucsonPhil TucsonPhil 4 주 전
Nvidia invested $50M in this company. ARK is a holder. This will be huge, once their first find gets FDA approval, and proof of concept is secured.
👍️ 1
bwrbad bwrbad 4 주 전
interesting no posters in this
future $200 - $300 stock, and that future not far - see the quality of clinical data, target diseases, and the time it took to reach there - not standard 20 ys but 3y to ph3 and a large advancing failure resistant AI powered pipeline
👍️0
bwrbad bwrbad 4 주 전
change of heart -going up.
👍️0
bwrbad bwrbad 4 주 전
rxrx WORLD
👍️0
bwrbad bwrbad 1 월 전
promised to accumulate 10k shares before Q end and hold for years. predict this issue never go BK, do RS, and one day go beyond 200+ like established big cap security issues.
👍️0
bwrbad bwrbad 1 월 전
bandwagon
👍️0
bwrbad bwrbad 1 월 전
believe in miracle ----- come to RXRX------
👍️0
TucsonPhil TucsonPhil 1 월 전
Looks like Lilly is late to the party.

https://www.statnews.com/2025/01/10/eli-lilly-andreessen-horowitz-500-million-venture-fund-ai-focus/
👍️0
bwrbad bwrbad 1 월 전
cursion-re-cursion in flame after FDA REC 3565 blessings
👍️0
bwrbad bwrbad 2 월 전
Gibson🤢🥵🥶😷Gibson
👍️0
bwrbad bwrbad 2 월 전
baby nvda
👍 1
bwrbad bwrbad 2 월 전
balding haircut at RXRX
👍️0
Monksdream Monksdream 2 월 전
RXRX, under $7
👍️0
bwrbad bwrbad 2 월 전
out for now, let CEO work his magic if he has one under his sleeve
👍️0
bwrbad bwrbad 2 월 전
is something wrong with RxRx, it looked promising based on what said to public. but something not right. ground shaken up. - like trouble.
what wrong with the CEO. if this continues that is bad sign for future of the company and the CEO.
👍️0
bwrbad bwrbad 2 월 전
RXRX
👍️0
bwrbad bwrbad 2 월 전
RxRx partnership: GOOG NVDA MSFT Roche/Genentech Bayer Bristol Myers Squibb Sanofi Merck ......
👍 1
bwrbad bwrbad 2 월 전
RxRx M&A: Valence –Cyclica - Exscientia
Valence – a leader in generative AI and deep learning models
Cyclica - a deep learning engine that predicts the polypharmacology of small molecules in drug discovery.
Exscientia - AI-driven precision medicine
RXRX - Regenerative AI - TechBio powerhouse
undergoing post merger reorganization, some job cuts
enough cash to fund through 2027
Ark Q3 2024 Stake: $215.9 million
Hedge Fund Investors Q3 2024:: 16
more than ten drugs in trials.
👍️0
bwrbad bwrbad 2 월 전
market up big and RxRx ignored,
if quantum computing which is 7-10 years away getting attention now, then this should be in the rocket heading for stratosphere.
👍️0
TucsonPhil TucsonPhil 2 월 전
RXRX seeing some promising results in early trials. Proof of concept will solidify belief in the platform.

If cost of trials can be reduced, by less attrition of candidates, then they should see more licensing agreements, and funding, from pharma companies IMO.
👍️ 1
bwrbad bwrbad 2 월 전
Revenue (ttm) 65.18M; Quarterly Revenue Growth (yoy) 147.60%
Total Cash (mrq) 427.65M; Total Debt (mrq) 90.62M
Shares Outstanding 6 388.94M; Float 8 252.42M
clinical trial : REC-994 in Phase 2, REC-2282 in Phase 2/3; few other in phase 1 and 2, all in less than 2 year not 15-18 years (conventional).

% Held by Institutions 1 69.40% Shares Short (Nov 15, 2024) 4 64.57M 25%
👍️ 1
JJ8 JJ8 2 월 전
Rxrx share price Long Tail Up since 06 Dec 2024.
👍️0
paperman paperman 2 월 전
Phase 1 news expected tonight at conference.
👍️0
paperman paperman 2 월 전
Phase 1 news expected tonight at conference.
👍️0
bwrbad bwrbad 2 월 전
this is one magnificent AI drug discovery platform - be household name like google tesla Microsoft ...
👍️0
JJ8 JJ8 3 월 전
Bought it yesterday at $6.60

Today it's up about 22%.

Same story with 2 other stocks and they all go up today more than 20%!

Whoa! IN CREDIBLE!
👍️0
TucsonPhil TucsonPhil 3 월 전
Agreed, but there will be wild swings, until they get their footing with clinical trials proving the concept works. Trade it until then, and keep one foot in the door for surprise announcements.
👍️0
bwrbad bwrbad 3 월 전
RxRx going to be top player in future pharma drug discovery
👍️0

최근 히스토리

NASDAQ
RXRX
Recursion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지